Exemple de utilizare a Controlled trial în Engleză și traducerile lor în Română
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Programming
Use controlled trials.
Table 2: Clinical Responses in Controlled Trials.
There are no controlled trials in paediatric patients with DFSP.
Responses of Patients with Psoriatic Arthritis in a Placebo- Controlled Trial.
There are no controlled trials in paediatric patients with MDS/MPD.
Oamenii se traduc, de asemenea,
Zoloft has produced 30 percent less side effects in a controlled trial the male adults.
There are no controlled trials in paediatric patients with DFSP.
Meloxicam and celecoxib have proven to be effective andsafe in children in a controlled trial.
In controlled trials the frequency of specific serious psychiatric events were.
The efficacy of Arava in the treatment of rheumatoid arthritis was demonstrated in 4 controlled trials(1 in phase II and 3 in phase III).
There are no controlled trials in paediatric patients with c-Kit positive GIST.
Cyclosporine, a drug used widely in organ transplants to suppress immune reaction,has been evaluated in one controlled trial.
KEYNOTE-002: Controlled trial in melanoma patients previously treated with ipilimumab.
If this trial will not start or otherwise fail to address the relevant issues, the applicant commits to re-discuss andagree with CHMP the possibility to conduct a randomised controlled trial(or agreed alternative design) in patients with amyloidosis.
KEYNOTE-010: Controlled trial in NSCLC patients previously treated with chemotherapy.
Adverse drug reactions to SIRTURO reported from controlled trials in 102 patients treated with SIRTURO are presented in the table below.
In the controlled trial of Copalia HCT, the counteracting effects of valsartan 320 mg and hydrochlorothiazide 25 mg on serum potassium approximately balanced each other in many patients.
The report concluded that,“The evidence from Random controlled trials(RCTs) suggests that Garcinia extracts/HCA generate weight loss on the short term.
The results of this controlled trial were expressed in percentage improvement in rheumatoid arthritis using American College of Rheumatology(ACR) response criteria.
Objective To systematically compare the outcomes of participants in randomised controlled trials(RCTs) with those in comparable non-participants who received the same or similar treatment.
In a placebo controlled trial, patients with inadequate glycaemic control despite a three month insulin optimisation period were randomised to pioglitazone or placebo for 12 months.
At present there are no results from controlled trials evaluating the effect of APTIVUS on clinical progression of HIV.
There are no controlled trials demonstrating a clinical benefit or increased survival.
The incidence of withdrawal due to adverse events during the 30-week controlled trial was 6% for prolonged-release exenatide treated patients, 5% for immediate-release exenatide treated patients.
Schizophrenia- in a long term 52-week controlled trial, aripiprazole-treated patients had an overall-lower incidence(25.8%) of EPS including Parkinsonism, akathisia, dystonia and dyskinesia compared with those treated with haloperidol(57.3%).
Manic episodes in Bipolar I Disorder- in a 12-week controlled trial, the incidence of EPS was 23.5% for aripiprazole-treated patients and 53.3% for haloperidol-treated patients.
Schizophrenia: in a long term 52-week controlled trial, aripiprazole-treated patients had an overall- lower incidence(25.8%) of EPS including parkinsonism, akathisia, dystonia and dyskinesia compared with those treated with haloperidol(57.3%).
Manic episodes in Bipolar I Disorder: in a 12-week controlled trial, the incidence of EPS was 23.5% for aripiprazole-treated patients and 53.3% for haloperidol-treated patients.
Efficacy is ideally determined by carrying out a controlled trial, in which some participants receive the intervention under test while a control group receives another intervention or no intervention, or, better still, in a randomised controlled trial, in which participants are randomly allocated to receive one of the two interventions(Cochrane Collaboration, 2007).
The long-term safety profile of efavirenz-containing regimens was evaluated in a controlled trial(006) in which patients received efavirenz+ zidovudine+ lamivudine(n= 412, median duration 180 weeks), efavirenz+ indinavir(n= 415, median duration 102 weeks), or indinavir+ zidovudine+ lamivudine(n= 401, median duration 76 weeks).